- Home
- RLAY vs NMIH Comparison
RLAY vs NMIH Comparison
Compare RLAY & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | NMIH |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | RLAY | NMIH |
|---|---|---|
| Price | $12.79 | $37.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $19.50 | ★ $43.25 |
| AVG Volume (30 Days) | ★ 3.6M | 376.1K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | 11.06 |
| EPS | N/A | ★ 4.92 |
| Revenue | $15,355,000.00 | ★ $706,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $324.03 | $4.34 |
| P/E Ratio | ★ N/A | $7.96 |
| Revenue Growth | ★ 53.44 | 8.52 |
| 52 Week Low | $2.71 | $34.84 |
| 52 Week High | $17.32 | $43.20 |
Technical Indicators
Market Signals| Indicator | RLAY | NMIH |
|---|---|---|
| Relative Strength Index (RSI) | 45.40 | 36.58 |
| Support Level | $6.67 | $36.14 |
| Resistance Level | $17.32 | $37.66 |
| Average True Range (ATR) | 1.05 | 1.06 |
| MACD | -0.54 | -0.21 |
| Stochastic Oscillator | 9.98 | 21.43 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.